In this study the relative affinities of natural lecithins and slightly modified lecithin analogues to the active site of porcine pancreatic phospholipase A, were determined.
Introduction
Phospholipase A, (EC3.1.1.4) is one of the smallest enzymes known today (molecular mass < 14 kDa). This ubiquitously occurring protein has an important function in the digestion of dietary phospholipids and in the maintenance of the structural integrity of biological membranes. The enzyme has an absolute requirement for CaZ+ ions and specifically hydrolyses the 2-ester bond in 1,2-diacyl-sn-3-glycerophosphatides (L-a-phospholipids). The stereoisomeric 2,3-diacyl-sn-l-glycerophosphatides (D-a-phospholipids) are pure competitive inhibitors for the enzyme. They bind with an identical affinity to the catalytic site, but are not hydrolysed [l] . In addition, it has been shown also that the isomeric 1,3-diacyl-sn-2-gIycerophosphatides are slowly degraded by phospholipase A, and with these so-called /3-phospholipids the enzyme attacks exclusively the sn-1 -ester bond [2] .
The majority of natural phospholipids contain saturated fatty acids in the sn-1-position, while the highly saturated linoleic-and arachidonic acids are mainly esterified to the glycero-sn-2-position; Taking into account that free arachidonic acid is the direct precursor of the inflammatory thromboxanes and prostaglandins, it is not surprising that active research is going on to find potent competitive inhibitors for phospholipase A,. For a recent review, see [3] .
Although X-ray structures have been reported for two pancreatic enzymes [4, 5] , and for one snake venom phospholipase A, [6] , highly diffracting protein crystals containing a single molecule of substrate or substrate analogue bound to the catalytic site, have not been obtained so far. In the present study, we describe the inhibitory properties of some phospholipids containing an acyl amino linkage instead of the normal ester bond. These substrate analogues, which are not degraded by phospholipase A,, are investigated now in X-ray crystallographic studies.
Materials and methods
The preparation of the various phospholipid substrates (Table 1 : 11, IV, VI, VIII) and inhibitors (Table 1: I, 111, V, VII) is not described here. Identification is as follows: I, rac-1 -palmitoyl-2-deoxy-2 -(myristoylamino)-3-glycero-
l-myristoyl-3-palmitoyl-sn-2-glycerophosphocholine; VII, l-palmitoyl-3-deoxy-3-(myristoylamino)-sn-2-glycerophosphocholine; VIII, 1 -palmitoyl-3-myristoyl-sn-2-glycerophosphocholine.
All synthetic 'lecithins' were chromatographically pure [h.p.t.l.c. on SiO, in CHCl,/MeOH/H20 (65:35:8, v/v)]. The indicated position of the acyl chains and the stereochemical purity of the various phospholipids was carefully checked by using a series of well-defined specific phospholipases and lipases.
Porcine pancreatic prosphospholipase A, was purified and converted into the corresponding phospholipase 4 as described [7] . Enzymic activity on the various synthetic lecithin substrates (pmol/min-I mg protein-I ) was determined by the pH-stat method at pH 8.5. Conditions: 5 mMTris/HCI; 10 mM-CaZ+ at 25°C; substrate concentration: 1 mM; sodium deoxycholate concentration: 1 mM. The inhibitory properties of the isomeric 'acy1amino'-lecithins were determined by similar titration assays keeping the sum of substrate k inhibitor concentration constant ( = 1 mM) (see below).
Reversible inhibition at interfaces. The kinetic model proposed by Verger et al. [8] to describe the action of a lipolytic enzyme can be extended to situations in which an inhibitor is also present in the substrate-containing interface. As shown in Fig. 1 , the inhibitor i will reversibly bind the adsorbed enzyme E* to give rise to the complex E*i characterized by the two-dimensional inhibition constant K,*. This leads to a reduction of the concentration of the productive complex E*S and consequently results in a lower enzymatic velocity.
Under saturating interface (phospholipid substate + inhibitor) conditions, all enzyme will be adsorbed to the lipids (E -E*) and the resulting enzymic velocity will be determined essentially by the ratio of the two-dimensional Michaelis-Menten constants: K,*/K:.
If the affinity of the adsorbed enzyme E* for its substrate and for the inhibitor are equal, a linear relationship between enzyme velocity and the mole fraction of inhibitor (S + i = constant!) can be expected. For the pancreatic phospholipase A, this possibility has indeed been experimentally verified [l]: Fig. 2 , curve 1 shows that sn-1-lecithins are pure competitive inhibitors for the enzyme when sn-3-lecithins containing the same long-chain fatty acids are used as substrate (K,* = K?).
If the adsorbed enzyme E* has a higher two-dimensional affinity for the inhibitor than for the substrate ( Ki* < Km*), 
theoretical curve for a pure competitive inhibitor with K i * < Km*[S+i]=constant.See [9] .
curves of the shape of line 2 (Fig. 2) can be expected. In this case the ratio of enzyme activities measured at 50% S and 50% i (mole fraction of S and i = 0.5) yields information on the relative affinities of the adsorbed enzyme E* for substrate and inhibitor in the interface (K,*/Ky). 
Results

Discussion
Inhibition studies of water-soluble lipolytic enzymes which act on water-insoluble substrates are complicated for several reasons. As illustrated in Fig. 1 , lipolysis is an example of heterogeneous catalysis: the water-soluble enzyme E has first to interact with the lipid-water interface (E * E*). Once in the interface, E* will bind one molecule of substrate giving rise to the two-dimensional Michaelis complex E*S. The ultimate enzymic velocity will be determined not only by the substrate specific term k,,, but also by the surface concentration of E*S. Even in the absence of an interfacial inhibitor i, the two-dimensional substrate concen- Table 1 . Schematic structural formulae of the 'monoacylamino'4ecithin inhibitors and corresponding diacyl-lecithins used as a substrate
The exact stereoconfiguration of the various lecithins I-VIII is given under Materials and methods. The kinetic properties of porcine pancreatic phospholipase A, are given in the last two columns.
0
II -P--N+ stands for -O-P-O-CH2-CH2
-N+(CH,), inhibitor.
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expressed in molecules/cm* cannot easily be varied. Therefore, even under the conditions where all enzyme is in the form E* (large substrate/water interface), the observed 'maximal velocity' has an apparent value [9] . Our interest in this study is focused on the relative affinities of the active site of phospholipase 4 for its natural substrate and for the (potential) inhibitor present in the interface, i.e. K,*/K:. A numerical value for this ratio can be obtained by the described technique, but only under welldefined conditions: ( a ) the total lipid-water interface (S + i)
should be large enough so that all the enzyme is adsorbed at the interface (E-E*); ( b ) the chemical structure of the inhibitor should resemble closely that of the substrate used to prevent phase separation; ( c ) taking into account the important contribution of hydrophobic interactions between the enzyme's active site and the lipid molecules, the substrate and inhibitor molecules should contain fatty acids of identical chain length.
To optimally fulfil the above requirements, we used four isomeric lecithins as substrates (Table 1 : 11, IV, V1 and VIII), all composed of myristic acid and one palmitic acid chain.
Because pancreatic phospholipase 4 is unable to attack bilayered aqueous lecithin dispersions, these substrates were solubilized as mixed micelles in water with 1 mM-sodium deoxycholate. Preliminary experiments showed that optically clear lecithin solutions (1 mM) in 1 mM deoxycholate provide a micellar lipid-water interface sufficient to convert all phospholipase in the form E*. Note in Table 1 the remarkable differences in substrate properties of the four isomeric lecithins! As regards potential inhibitors, we decided to introduce a minimal structural replacement in the substrate molecule, namely the substitution of one -0-CO group by the NH-CO function. Differential scanning calorimetric studies of the ester and acylaminolecithins showed very similar T,-values, which makes phase separation of these phospholipids very improbable (results not shown). Therefore from the last column in Table 1 , an important conclusion can be drawn: the large differences in the affinity of the enzyme's active site for substrate and inhibitor (factor of 10 and 11) are probably not caused by physicochemical differences of the lipid-water interfaces. On the contrary, it is evident that the fine chemical structure around the susceptible ester bond determines to a large extent the affinity of the phospholipid molecule for the enzyme's active site. The observation that only the replacement of the phospholipase-susceptible ester bond by an acylamino linkage gives rise to a 10-fold higher affinity to the catalytic site, strongly supports the idea that these particular 'acylamino-lecithins' behave like transition-state inhibitors.
Similar inhibition studies of phospholipase A? using 'acylamino-lecithins' have been reported earlier [ 1, 101, but in these studies not sufficient attention has been paid to the required experimental conditions. Note added in proof (Fig. 2) , is not equal but proportional to K : / K : .
The ratio of enzymic activities measured at 50% S and 50% i
Introduction
The glucocorticosteroids are the most useful anti-inflammatory drugs that we possess, effective against virtually any type of inflammation, and are among the most widely prescribed drugs in the world. The naturally occurring hormone hydrocortisone is still used clinically, but in many cases it has been superseded by synthetic analogues which have vastly increased duration of action and potency.
Our knowledge concerning the anti-inflammatory mechanism of action of glucocorticoids is still vague, but at least some of the effects of glucocorticoids appear to be the result of inhibition of the activity of phospholipase A, (PLA,). This enzyme, which is abundant in most cells is important because it can control the liberation of arachidonic acid, the substrate of both the cyclo-oxygenase (which produces prostanoids) and lipoxygenase (which produces hydroxyfatty acids, the precursors of leukotrienes) enzymes and also liberate lyso-PAF, the precursor of the potent lipid mediator platelet-activating factor (PAR 1 -0-acyl, 2-alkylglycero-3-phosphocholine). PLA, activation may therefore be a key event in the release from cells of a variety of mediators with potentially pro-inflammatory actions.
Mechanism of action of the glucocorticoids
Glucocorticoids do not inhibit phospholipase directly, but act by the 'classic pathway' of steroid action, i.e. occupation of a cytoplasmic steroid receptor, interaction of the receptor complex with nuclear DNA, formation of mRNA and, subsequently, new protein synthesis. When exposed to glucocorticoids, many cells produce a protein with phospholipase inhibitory activity. Such protein( s) were discovered inde- 
